They found that patients positive for both amyloid and tau exhibited more extensive hypometabolism in the lateral temporal, parietal, and occipital lobes compared to those who were tau-negative and either amyloid-positive or amyloid-negative. This evidence concerns the gene MAPT and amyloidosis.